Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00977080 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 272
- Enrollment target
NCT00977080: Completed Phase 4 study, sponsored by Abbott.
NCT00977080 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 272 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00977080, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 272 participants
- Enrollment target
Study Summary
Evaluates the effectiveness of on-label Paricalcitol versus Cinacalcet with Low-Dose Vitamin D.
Primary Outcome
iPTH values obtained during the evaluation period (Weeks 21 to 28) were averaged for each participant with at least 2 iPTH values. Participants whose average iPTH value was between 150 to 300 pg/mL were counted.
Interventions
- DRUG Paricalcitol
- DRUG Cinacalcet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
What the finished NCT00977080 record still lists
NCT00977080 is an interventional study that assigns participants to a tested intervention. The registered 272 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Paricalcitol is the first listed.
NCT00977080 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00977080 about?
NCT00977080 is a clinical study titled "Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D". Evaluates the effectiveness of on-label Paricalcitol versus Cinacalcet with Low-Dose Vitamin D.
What is the current status of trial NCT00977080?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 272 participants. The study started on 2009-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00977080?
The interventions under investigation include: Paricalcitol (DRUG), Cinacalcet (DRUG).
Who is sponsoring clinical trial NCT00977080?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00977080's enrollment target sits among peer trials
272 316th of 2000 higher than 1,685 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
- NCT06083051 · 272 participants · NA
Differences in Postoperative Symptoms With Four Ureteral Stents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia